Press Releases July 27, 2026 04:01 PM

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Carlsmed Announces Participation in Key Upcoming Investor Conferences

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
CARL

Carlsmed, Inc., a medical technology company specializing in AI-enabled personalized spine surgery solutions, announced its management team's participation in two upcoming virtual investor conferences in August 2026, including the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference and the Bank of America SMID Cap Virtual Conference. These events will feature one-on-one meetings and a fireside chat, providing opportunities to engage with investors and discuss company developments.

Carlsmed, Inc. To Participate in Upcoming Investor Conferences
CARL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Carlsmed is focusing on AI-enabled personalized spine surgery technology, impacting the medical technology and healthcare sectors.
  • Management will participate in prominent virtual investor conferences, enhancing investor relations and visibility.
  • The company offers live and archived webcasts to facilitate investor engagement and transparency.

CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced that management will participate in the following investor conferences:

  • 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The Company will host one-on-one meetings on Monday, August 10, 2026.
  • Bank of America SMID Cap Virtual Conference. Fireside chat on Wednesday, August 12, 2026, at 11:00 AM ET. A live webcast will be available to registered participants. Investors interested in participating in virtual one-on-one meetings should contact their Bank of America representative.

A live and archived webcast of the Bank of America SMID Cap Virtual Conference will be available in the Events & Presentations section of the company’s investor website at investors.carlsmed.com.

About Carlsmed

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
[email protected]

Media
[email protected]
  


Risks

  • Market reception to the company's technology and growth potential remains uncertain, influencing investor sentiment in the medtech sector.
  • Virtual conference participation may have limited impact if broader market or sector conditions are unfavorable.
  • Competitive pressures in the medical technology industry could affect Carlsmed's ability to capitalize on investor interest.

More from Press Releases

Blue Gold Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency Jul 27, 2026 Mueller Water Products Announces Dates for Third Quarter 2026 Earnings Release and Conference Call Jul 27, 2026 Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026 Jul 27, 2026 Millicom (Tigo) notice of second quarter 2026 results and video conference Jul 27, 2026 Celestica Announces Second Quarter 2026 Financial Results Jul 27, 2026